Abstract
Objective
The objective of this study was to conduct a systematic review of the measurement properties and methodological quality of stigma assessment tools designed for breast cancer patients. The aim was to provide clinical medical staff with a foundation for selecting high-quality assessment tools.
Methods
A comprehensive computer search was carried out across various databases, including SinoMed, China National Knowledge Infrastructure (CNKI), Wanfang Database, China Science and Technology Journal Database(VIP), Embase, PubMed, Web of Science, The Cochrane Library, and Scopus, which were searched from the inception of the databases until March 20, 2023. Literature screening and data extraction were performed independently by two researchers, adhering to predefined inclusion and exclusion criteria. The assessment tools were evaluated using the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) systematic evaluation guidelines.
Results
In the final analysis, a total of 9 assessment tools were included. However, none of these tools addressed measurement error, cross-cultural validity, criterion validity, and responsiveness. Following the COSMIN guidelines, BCSS and CSPDS were assigned to Class A recommendations, while the remaining tools received Class B recommendations.
Conclusion
The BCSS and CSPDS scales demonstrated comprehensive assessment in terms of their measurement characteristics, exhibiting good methodological quality, measurement attribute quality, and supporting evidence. Therefore, it is recommended to utilize these scales for evaluating breast cancer stigma. However, further validation is required for the remaining assessment tools.
Similar content being viewed by others
Data Availability
All the data are available from the corresponding author up on a reasonable request.
References
Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
Zeng H, Chen W, Zheng R et al (2018) Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health 6(5):e555–e567. https://doi.org/10.1016/S2214-109X(18)30127-X
Miller KD, Siegel RL, Lin CC et al (2016) Cancer treatment and survivorship statistics, 2016. CA Canc J Clin 66(4):271–289
Lovelace DL, McDaniel LR, Golden D (2019) Long-term effects of breast cancer surgery, treatment, and survivor care. J Midwifery Womens Health 64:713–724. https://doi.org/10.1111/jmwh.13012
Corrigan PW, Kerr A, Knudsen L (2005) The stigma of mental illness: Explanatory models and methods for change. Appl Prev Psychol 11:179–190. https://doi.org/10.1016/j.appsy.2005.07.001
Suwankhong D, Liamputtong P (2016) Breast cancer treatment: experiences of changes and social stigma among Thai women in Southern Thailand. Cancer Nurs 39:213–220. https://doi.org/10.1097/NCC.0000000000000255
Bogart LM, Cowgill BO, Kennedy D et al (2008) HIV-related stigma among people with HIV and their families: a qualitative analysis. AIDS Behav 12(2):244–254. https://doi.org/10.1007/s10461-007-9231-x
Corrigan PW, Watson AC, Barr L (2006) The self-stigma of mental illness: Implications for self-esteem and self-efficacy. J Soc Clin Psychol 25:875–884. https://doi.org/10.1521/jscp.2006.25.8.875
Corrigan PW, Watson AC (2002) The paradox of self-stigma and mental illness. Clin Psychol Sci Pract 9:35. https://doi.org/10.1093/clipsy.9.1.35
Jin J (2022) Factors associated with the quality of work life among working breast cancer survivors. Asia-Pac J Oncol Nur 9:97–104. https://doi.org/10.1016/j.apjon.2021.11.005
Major B, O’brien LT (2005) The social psychology of stigma. Annu Rev Psychol 56:393–421. https://doi.org/10.1146/annurev.psych.56.091103.07013
Chan KK, Mak WW (2014) The mediating role of self-stigma and unmet needs on the recovery of people with schizophrenia living in the community. Qual Life Res 23:2559–2568. https://doi.org/10.1007/s11136-014-0695-7
Bedi M, Devins GM (2016) Cultural considerations for South Asian women with breast cancer. J Cancer Surviv 10(1):31–50. https://doi.org/10.1007/s11764-015-0449-8
Al-Qadire M, Alkhawaldeh S (2018) Understanding the perceptions and experiences of Jordanian women towards breast cancer screening. J Cancer Educ 34(2):341–348
Xing G (2013) Buddhist impact on Chinese culture. Asian Philos 23:305–322. https://doi.org/10.1080/09552367.2013.831606
Dolezal L, Lyons B (2017) Health-related shame: an affective determinant of health? Med Humanit 43:257–263. https://doi.org/10.1136/medhum-2017-011186
Phelan SM, Griffin JM, Jackson GL et al (2013) Stigma, perceived blame, self-blame, and depressive symptoms in men with colorectal cancer. Psychooncology 22(1):65–73. https://doi.org/10.1002/pon.2048
Cho J, Choi EK, Kim SY et al (2013) Association between cancer stigma and depression among cancer survivors: a nationwide survey in Korea. Psychooncology 22(10):2372–2378. https://doi.org/10.1002/pon.3302
Holubova M, Prasko J, Ociskova M et al (2019) Quality of life, self-stigma, and coping strategies in patients with neurotic spectrum disorders: a cross-sectional study. Psychol Res Behav Manag 1(12):81–95. https://doi.org/10.2147/PRBM.S179838
Tang WZ, Yusuf A, Jia K et al (2022) Correlates of stigma for patients with breast cancer: a systematic review and meta-analysis. Support Care Cancer 31(1):55. https://doi.org/10.1007/s00520-022-07506-4
Ernst J, Mehnert A, Dietz A et al (2017) Perceived stigmatization and its impact on quality of life—Results from a large register-based study including breast, colon, prostate and lung cancer patients. BMC Cancer 17:741. https://doi.org/10.1186/s12885-017-3742-2
Tripathi L, Datta SS, Agrawal SK et al (2017) Stigma perceived by women following surgery for breast cancer. Indian J Med Paediatr Oncol 38:146–152. https://doi.org/10.4103/ijmpo.ijmpo_74_16
Odigie VI, Tanaka R, Yusufu LM et al (2010) Psychosocial effects of mastectomy on married African women in Northwestern Nigeria. Psychooncology 19(8):893–897. https://doi.org/10.1002/pon.1675
Florescu M, Cinteza M, Vinereanu D (2013) Chemotherapy-induced cardiotoxicity. Maedica (Bucur) 8:59–67
Jørgensen TL, Hallas J, Friis S et al (2012) Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 106:1353–1360. https://doi.org/10.1038/bjc.2012.46
Amini-Tehrani M, Zamanian H, Daryaafzoon M et al (2021) Body image, internalized stigma and enacted stigma predict psychological distress in women with breast cancer: A serial mediation model. J Adv Nurs 77(8):3412–3423
Smith AW, Reeve BB, Bellizzi KM et al (2008) Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev 29(4):41–56
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79
Kotronoulas G, Kearney N, Maguire R et al (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care?A systematic review of controlled trials. J Clin Oncol 32(14):1480–1501
Gordon BE, Chen RC (2017) Patient-reported outcomes in cancer survivorship. Acta Oncol 56(2):166–173
Mokkink LB, de Vet HC, Prinsen CA et al (2018) COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res 27(5):1171–1179. https://doi.org/10.1007/s11136-017-1765-4
Wei Y, McGrath P, Hayden J et al (2018) The quality of mental health literacy measurement tools evaluating the stigma of mental illness: a systematic review. Epidemiol Psychiatr Sci 27(5):433–462. https://doi.org/10.1017/S2045796017000178
Yang X, Zhang Y, Han S et al (2023) Patient-reported outcome measures of stigma and discrimination for people living with HIV: a systematic review protocol. JBI Evid Synth 21(9):1838–1846. https://doi.org/10.11124/JBIES-22-00314
Prinsen CAC, Mokkink LB, Bouter LM et al (2018) COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res 27(5):1147–1157
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol 134:178–189. https://doi.org/10.1016/j.jclinepi.2021.03.001
Terwee CB, Mokkink LB, Knol DL et al (2012) Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 21(4):651–657
Terwee CB, Prinsen CAC, Chiarotto A et al (2018) COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res 27(5):1159–1170
Terwee CB, Bot SD, de Boer MR et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34–42
Alhazzani W, Guyatt G (2018) An overview of the GRADE approach and a peek at the future. Med J Aust 209(7):291–292
Bu X, Li S, Cheng ASK et al (2022) Breast cancer stigma scale: a reliable and valid stigma measure for patients with breast cancer. Front Psychol 10(13):841280
Daryaafzoon M, Amini-Tehrani M, Zohrevandi Z et al (2020) Translation and factor analysis of the stigma scale for chronic illnesses 8-item version among iranian women with breast cancer. Asian Pac J Cancer Prev 21(2):449–455
Dewan MF, Hassouneh D, Song M et al (2020) Development of the breast cancer stigma scale for Arab patients. Asia Pac J Oncol Nurs 7(3):295–300
Paltun B, Bölükbaş N (2021) Turkish version of the cancer stigma scale: validity and reliability study. Psychol Health Med 26(sup1):37–48
Li RX, Jiang ZL, Gong SM et al (2019) Credit validity study of the Chinese stigma experience questionnaire in breast cancer patients. Chin J Pract Nurs Care 28:2195–2199
Feng LS, Li XY, Wang HR et al (2018) Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients. Health Qual Life Outcomes 16(1):165
Yılmaz M, Dişsiz G, Demir F et al (2017) Reliability and validity study of a tool to measure cancer stigma: patient version. Asia Pac J Oncol Nurs 4(2):155–161
So HS, Chae MJ, Kim HY (2017) Reliability and validity of the Korean version of the cancer stigma scale. J Korean Acad Nurs 47(1):121–132
Tsuchiya M, Horn S, Ingham R (2012) Development of the Psycho-social Discomfort Scale (PsDS): investigation of psychometric properties among Japanese breast cancer survivors. Psychooncology 21(2):161–167
Peng J, Shen LJ, Chen WT et al (2020) Interpretation of measurement tool stability, measurement error and study risk of bias in the COSMIN-RoB list. Chin J Evid Based Med 20(11):1340–1344
Shi YX, Zhang HM, Huang YQ et al (2021) Interpretation of the consensus criteria (COSMIN) bias risk assessment list for selecting health measurement tools. Nurs Manage China 21(07):1053–1057
Gao Y, Zhao JF, Xu LL et al (2020) The evaluation of the COSMIN operating guide on the Chinese version of the electronic health literacy scale. Chin J Gerontol 40(09):1968–1973
Funding
This research project was supported by Project approved by Sichuan Mental Health Education Research Center (XLJKJY2203A).
Author information
Authors and Affiliations
Contributions
Xie conceived the idea for this paper and completing paper writing. Bai Chen and Li did the screening and data extraction. Chen and Li conducted the statistical analysis. Gao reviews the manuscript and provides suggestions for revisions. All authors have read and approved the final manuscript, and had final responsibility for the decision to submit for publication.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xie, X., Gao, J., Bai, D. et al. Assessment tools for stigma in breast cancer patients based on COSMIN guidelines: a systematic review. Support Care Cancer 32, 65 (2024). https://doi.org/10.1007/s00520-023-08276-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00520-023-08276-3